156 related articles for article (PubMed ID: 18515083)
1. Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification.
Okazaki M; Usui S; Nakamura M; Yamashita S
Clin Chim Acta; 2008 Sep; 395(1-2):62-7. PubMed ID: 18515083
[TBL] [Abstract][Full Text] [Related]
2. Comparative study between anion-exchange HPLC and homogeneous assay methods in regard to the accuracy of high- and low-density lipoprotein cholesterol measurement.
Kurosawa H; Yoshida H; Yanai H; Ogura Y; Hirowatari Y; Tada N
Clin Biochem; 2007 Nov; 40(16-17):1291-6. PubMed ID: 17826753
[TBL] [Abstract][Full Text] [Related]
3. Measurement of cholesterol concentrations of major serum lipoprotein classes in haemodialysis patients by anion-exchange chromatography.
Hirowatari Y; Yoshida H; Fueki Y; Ito M; Ogura Y; Sakurai N; Miida T
Ann Clin Biochem; 2008 Nov; 45(Pt 6):571-4. PubMed ID: 18782818
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a gel-permeation high-performance liquid chromatography for determining triglyceride levels in serum major lipoproteins, compared with the ultracentrifugation/precipitation method.
Usui S; Mizuno T; Okazaki M; Nakamura M; Sakurabayashi I
Clin Biochem; 2009 Jan; 42(1-2):114-7. PubMed ID: 18996105
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population.
Tremblay AJ; Morrissette H; Gagné JM; Bergeron J; Gagné C; Couture P
Clin Biochem; 2004 Sep; 37(9):785-90. PubMed ID: 15329317
[TBL] [Abstract][Full Text] [Related]
6. High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men.
Deguchi H; Pecheniuk NM; Elias DJ; Averell PM; Griffin JH
Circulation; 2005 Aug; 112(6):893-9. PubMed ID: 16087810
[TBL] [Abstract][Full Text] [Related]
7. A novel and precise method for simultaneous measurement of serum HDL and LDL subfractions and lipoprotein (a) cholesterol by ultracentrifugation and high-performance liquid chromatography.
Dong J; Guo H; Yang R; Li H; Wang S; Zhang J; Zhou W; Chen W
Clin Chim Acta; 2012 Jul; 413(13-14):1071-6. PubMed ID: 22406178
[TBL] [Abstract][Full Text] [Related]
8. CETP and oxidized LDL levels increase in dyslipidemic subjects.
Wang J; Gu Q; Li K; Zhang C
Clin Biochem; 2007 Sep; 40(13-14):995-9. PubMed ID: 17658505
[TBL] [Abstract][Full Text] [Related]
9. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography.
Okazaki M; Usui S; Ishigami M; Sakai N; Nakamura T; Matsuzawa Y; Yamashita S
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):578-84. PubMed ID: 15637308
[TBL] [Abstract][Full Text] [Related]
10. Multicentric evaluation of the homogeneous LDL-cholesterol Plus assay: comparison with beta-quantification and Friedewald formula.
Esteban-Salan M; Aguilar-Doreste JA; Arranz-Pena ML; Juve-Cuxart S; Gich-Salarich I; Zapico-Muniz E; Ordonez-Llanos J
Clin Biochem; 2008 Nov; 41(16-17):1402-9. PubMed ID: 18722364
[TBL] [Abstract][Full Text] [Related]
11. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
[TBL] [Abstract][Full Text] [Related]
12. [Multicenter evaluation of four homogenous LDL-cholesterol assays].
Bayer P; Veinberg F; Couderc R; Cherfils C; Cambillau M; Cosson C; Fradin S; Gillery P; Steinmetz J; Legrand A; Egloff M; Beucler I
Ann Biol Clin (Paris); 2005; 63(1):27-41. PubMed ID: 15689310
[TBL] [Abstract][Full Text] [Related]
13. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
14. Differential reactivities of four homogeneous assays for LDL-cholesterol in serum to intermediate-density lipoproteins and small dense LDL: comparisons with the Friedewald equation.
Yamashita S; Kawase R; Nakaoka H; Nakatani K; Inagaki M; Yuasa-Kawase M; Tsubakio-Yamamoto K; Sandoval JC; Masuda D; Ohama T; Nakagawa-Toyama Y; Matsuyama A; Nishida M; Ishigami M
Clin Chim Acta; 2009 Dec; 410(1-2):31-8. PubMed ID: 19751710
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein.
Kappelle PJ; Zwang L; Huisman MV; Banga JD; Sluiter WJ; Dallinga-Thie GM; Dullaart RP
Expert Opin Ther Targets; 2009 Jul; 13(7):743-51. PubMed ID: 19505224
[TBL] [Abstract][Full Text] [Related]
16. Significance of dyslipidaemia in patients with heart failure of unexplained aetiology.
Skwarek M; Bilińska ZT; Mazurkiewicz Ł; Grzybowski J; Kruk M; Kurjata P; Piotrowski W; Ruzyłło W
Kardiol Pol; 2008 May; 66(5):515-22, discussion 523-4. PubMed ID: 18537059
[TBL] [Abstract][Full Text] [Related]
17. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
[TBL] [Abstract][Full Text] [Related]
18. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of lipoprotein analysis method by HPLC].
Yoshida H
Rinsho Byori; 2010 Nov; 58(11):1093-8. PubMed ID: 21229707
[TBL] [Abstract][Full Text] [Related]
20. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
